Immunomedics Develops T-Cell Redirecting Bispecific Antibodies as Potential ... MarketWatch (press release) The use of bispecific antibodies to redirect T cells for the killing of targeted tumor cells has shown considerable promise both preclinically and clinically. The Company has previously reported the generation of (19)-3s, a prototype bispecific ... |
